RUSH UNIVERSITY MEDICAL CENTER
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1837-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://www.rush.edu/
Topotecan and Thalidomide in Treating Patients With Recurrent or Refractory Malignant Glioma
Phase 2
Terminated
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2023-01-09
- Lead Sponsor
- Rush University Medical Center
- Target Recruit Count
- 5
- Registration Number
- NCT00014443
- Locations
- 🇺🇸
Rush Cancer Institute at Rush University Medical Center, Chicago, Illinois, United States
Longitudinal Study of the Menopause and Fat Patterning
Completed
- Conditions
- First Posted Date
- 2002-05-06
- Last Posted Date
- 2023-06-18
- Lead Sponsor
- Rush University Medical Center
- Target Recruit Count
- 868
- Registration Number
- NCT00035659
Prevalence & Progression of Subclinical Atherosclerosis
- First Posted Date
- 2000-11-17
- Last Posted Date
- 2014-05-01
- Lead Sponsor
- Rush University Medical Center
- Registration Number
- NCT00006503
© Copyright 2024. All Rights Reserved by MedPath